James G. Kublin

11.0k total citations
100 papers, 3.7k citations indexed

About

James G. Kublin is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James G. Kublin has authored 100 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 37 papers in Virology and 35 papers in Public Health, Environmental and Occupational Health. Recurrent topics in James G. Kublin's work include HIV Research and Treatment (37 papers), Malaria Research and Control (26 papers) and Mosquito-borne diseases and control (18 papers). James G. Kublin is often cited by papers focused on HIV Research and Treatment (37 papers), Malaria Research and Control (26 papers) and Mosquito-borne diseases and control (18 papers). James G. Kublin collaborates with scholars based in United States, South Africa and Malawi. James G. Kublin's co-authors include Padmaja Patnaik, Christopher V. Plowe, Terrie E. Taylor, Laith J. Abu‐Raddad, Malcolm E. Molyneux, Joseph F. Cortese, Peter Winstanley, Fraction K. Dzinjalamala, Jack J. Wirima and Abdoulaye Djimdé and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

James G. Kublin

94 papers receiving 3.6k citations

Peers

Countries citing papers authored by James G. Kublin

Since Specialization

Citations

This map shows the geographic impact of James G. Kublin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James G. Kublin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James G. Kublin more than expected).

Fields of papers citing papers by James G. Kublin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James G. Kublin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James G. Kublin. The network helps show where James G. Kublin may publish in the future.

Co-authorship network of co-authors of James G. Kublin

This figure shows the co-authorship network connecting the top 25 collaborators of James G. Kublin. A scholar is included among the top collaborators of James G. Kublin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James G. Kublin. James G. Kublin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct gastrointestinal microbial signatures predict parasite levels in controlled Plasmodium infections in both rhesus macaques and humans 2025 ·Nature Communications ·(unknown), Courtney A. Broedlow, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kathryn A. Guerriero, Kristina De Paris, Berlin Londoño-Rentería, Michael Gale, Nichole R. Klatt, James G. Kublin, Jennifer A. Manuzak	0
2	Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March – December 2021 2024 ·Vaccine ·Nadja A. Vielot, (unknown), Christina Ludema, Molly Rosenberg, Elizabeth R. Brown, Holly Janes, James G. Kublin, Kathryn E. Stephenson, Jasmine R Marcelin, Audrey Pettifor	0
3	Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis 2024 ·Nature Communications ·One Dintwe, Lamar Ballweber-Fleming, Valentin Voillet, John McNevin, Aaron Seese, (unknown), Saleha Omarjee, Linda‐Gail Bekker, James G. Kublin, Stephen C. De Rosa, Evan W. Newell, Andrew Fioré-Gartland, Erica Andersen‐Nissen, M. Juliana McElrath	4
4	Pre–Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T Cells and HIV Risk Among Heterosexual Individuals in Africa 2024 ·The Journal of Infectious Diseases ·(unknown), (unknown), (unknown), Myo Minn Oo, (unknown), (unknown), (unknown), Katherine K. Thomas, Connie Celum, Nelly Mugo, Andrew Mujugira, James G. Kublin, Lawrence Corey, Aida Sivro, Jairam R. Lingappa, (unknown), Lyle R. McKinnon	1
5	COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective 2022 ·Open Forum Infectious Diseases ·Jasmine R Marcelin, Audrey Pettifor, Holly Janes, Elizabeth R. Brown, James G. Kublin, Kathryn E. Stephenson	26
6	Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials 2022 ·Frontiers in Immunology ·(unknown), Dianna Hergott, Annette M. Seilie, (unknown), (unknown), Ming Chang, James G. Kublin, Thomas G. Egwang, Sean C. Murphy	5
7	Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk 2021 ·PLoS Pathogens ·Erica Andersen‐Nissen, Andrew Fioré-Gartland, Lamar Ballweber-Fleming, Lindsay N. Carpp, (unknown), Michael S. Harper, Valentin Voillet, Nicole Grunenberg, Fatima Laher, Craig Innes, Linda‐Gail Bekker, James G. Kublin, Ying Huang, Guido Ferrari, Georgia D. Tomaras, Glenda Gray, Peter B. Gilbert, M. Juliana McElrath	20
8	PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection 2021 ·PLoS Pathogens ·Sean C. Murphy, Gregory A. Deye, B. Kim Lee Sim, (unknown), Jessie K. Kennedy, Kristen W. Cohen, Sumana Chakravarty, Natasha KC, Yonas Abebe, Eric R. James, James G. Kublin, Stephen L. Hoffman, Thomas L. Richie, Lisa A. Jackson	32
9	Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs 2017 ·Malaria Journal ·Amelia Hanron, Zachary P. Billman, Annette M. Seilie, Tayla M. Olsen, Matthew Fishbaugher, Ming Chang, Thomas Rueckle, Nicole Andenmatten, Bryan Greenhouse, Emmanuel Arinaitwe, John Rek, Smita Das, Gonzalo J. Domingo, Kelly J. Shipman, Stefan H. I. Kappe, James G. Kublin, Sean C. Murphy	9
10	Selection of HIV vaccine candidates for concurrent testing in an efficacy trial 2016 ·Current Opinion in Virology ·Ying Huang, (unknown), Carlos A. DiazGranados, Holly Janes, (unknown), (unknown), Allan C. deCamp, Barbara Metch, Shannon Grant, Brittany Sanchez, Sanjay Phogat, Marguerite Koutsoukos, Niranjan Kanesa-thasan, Patricia Bourguignon, Alix Collard, Susan Buchbinder, Georgia D. Tomaras, M. Juliana McElrath, Glenda Gray, James G. Kublin, Lawrence Corey, Peter B. Gilbert	7
11	HLA-B58:02-specific benefit of MRKAd5 Gag/Pol/Nef vaccine in an African population 2015 ·Journal of the International AIDS Society* ·Ellen M. Leitman, Jillian H. Hurst, Matilde Mori, (unknown), Nicole Frahm, James G. Kublin, Glenda Gray, (unknown)	1
12	Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi 2015 ·The Journal of Infectious Diseases ·Elena Artimovich, Kristan A. Schneider, Terrie E. Taylor, James G. Kublin, Fraction K. Dzinjalamala, Ananías A. Escalante, Christopher V. Plowe, Miriam K. Laufer, Shannon Takala‐Harrison	26
13	Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men 2015 ·PLoS ONE ·Zoe Moodie, Barbara Metch, Linda‐Gail Bekker, Gavin Churchyard, Maphoshane Nchabeleng, Koleka Mlisana, Fatima Laher, Surita Roux, Kathryn Mngadi, Craig Innes, Matsontso Mathebula, Mary Allen, Carter Bentley, Peter B. Gilbert, Michael Robertson, James G. Kublin, Lawrence Corey, Glenda Gray	25
14	The Immune Space: A Concept and Template for Rationalizing Vaccine Development 2014 ·AIDS Research and Human Retroviruses ·Amapola Manrique, Elizabeth M. Adams, Dan H. Barouch, Pat Fast, Barney S. Graham, Jérôme H. Kim, James G. Kublin, (unknown), Giuseppe Pantaleo, Harriet L. Robinson, Nina D. Russell, W. F. Snow, Margaret I. Johnston	10
15	Lessons Learned from HIV Vaccine Clinical Efficacy Trials 2014 ·Current HIV Research ·(unknown), James G. Kublin	24
16	In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities 2013 ·AIDS Research and Human Retroviruses ·Holly Janes, Peter B. Gilbert, Susan Buchbinder, James G. Kublin, Magdalena E. Sobieszczyk, Scott M. Hammer	15
17	Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine 2011 ·Journal of Clinical Investigation ·Nicole Frahm, Allan C. deCamp, (unknown), Donald K. Carter, Olivier Defawe, James G. Kublin, Danilo R. Casimiro, Ann Duerr, Michael Robertson, Susan Buchbinder, Yunda Huang, (unknown), Stephen C. De Rosa, M. Juliana McElrath	110
18	Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa 2006 ·Science ·Laith J. Abu‐Raddad, Padmaja Patnaik, James G. Kublin	353
19	Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: Authors' reply 2004 ·BMJ ·Christopher V. Plowe, James G. Kublin, Fraction K. Dzinjalamala, (unknown), (unknown), Phillips Chimpeni, Malcolm E. Molyneux, Terrie E. Taylor	3
20	Reemergence of Chloroquine‐Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi 2003 ·The Journal of Infectious Diseases ·James G. Kublin, Joseph F. Cortese, Eric M. Njunju, (unknown), Jack J. Wirima, Peter N. Kazembe, Abdoulaye Djimdé, Bourèma Kouriba, Terrie E. Taylor, (unknown)	409

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact